Chester Donnally, MD
Orthopaedic Surgery of the Spine · Addison, TXNPI 1730506072
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.7%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Evolution Spine, LLC at 30.8% of the total. Reporting peaked in 2023 at $63,232 and has fallen 80.1% since, to $12,559 in 2025.
Across 195 payments — averaging $628.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evolution Spine, LLC$38K
- Fuse Medical, Inc.$25K
- Bioventus LLC$17K
- Osseus Fusion Systems, LLC$10K
- Globus Medical$10K
- The Institute Of Musculoskeletal Science And Education$6K
- plus $17K from 33 others
What the payments were for
- Royalty or licence$29,77324%
- Consulting fees$59,73449%
- Speaking & faculty fees$19,52516%
- Travel & lodging$6,7746%
- Food & beverage$6,1085%
- Education$6371%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Integrated ALIF System$24,492
- Emerge Anterior Cervical Plate System$13,293
- BoneScalpel$10,781
- Quartex$8,305
- BONESCALPEL & SONICONE (O.R.)$4,844
- OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM$2,500
- dualX$2,400
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$1,500
- NEXUS-10 MKII$1,250
- Orthros$1,050
- ANCHOR C$691
- ESCALATE$691
- XIA$691
- SERRATO$691
- OASYS$691
- YUKON$510
- BIOLOGICS$433
- COMBOGESIC IV$421
- MAZOR X SYSTEM$412
- nanoLOCK-C$327
How this compares
$122,551 in reported general payments places this provider in the 80th percentile of 207 orthopaedic surgery of the spine providers in Texas.
See all orthopaedic surgery of the spine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $589 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $520 |
| Cyclobenzaprine Hcl | 34 | $515 |
| Oxycodone Hcl | 57 | $399 |
| Methocarbamol | 42 | $388 |
| Gabapentin | 39 | $346 |
| Methylprednisolone | 45 | $278 |
| Pregabalin | 11 | $168 |
| Tramadol Hcl | 26 | $125 |
| Ondansetron Hcl | 14 | $51 |
| Meloxicam | 28 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Addison
- Andrew ParkAddison$304K
- Randall DryerAustin$2.9M
- Craig KuhnsAustin$2.4M
- David WimberleyHouston$2.2M
- Jeffrey PhelpsNorth Richland Hills$1.9M
- Eric WieserArlington$1.5M
- Andrew ClavennaDallas$1.3M
- Ivan ChengKyle$1.2M
- Stephen TolhurstFlower Mound$1.1M
- Michael ObrienPlano$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.